The ligand/RAGE axis: lighting the fuse and igniting vascular stress.

Current Atherosclerosis Reports
Shi Fang YanAnn Marie Schmidt

Abstract

Vascular inflammation contributes critically to the initiation and progression of atherosclerosis. These processes are accelerated in hyperglycemia and play key roles in the increased incidence and severity of myocardial infarction and stroke observed in diabetes. Evidence suggests that the ligands of the receptor for advanced glycation endproducts (RAGE), a multiligand member of the immunoglobulin superfamily, interact with this receptor to play important roles in both early development and progression of atherosclerosis and vascular inflammation. Studies in animal models of vascular injury underscored the potent impact of RAGE blockade; administration of ligand-binding decoys of RAGE or antibodies to the receptor reduced the consequences of diabetes, hyperlipidemia, and physical injury to the vessel wall. This review focuses on the ligand repertoire of RAGE, the impact of ligand-RAGE interaction, and the potent effect of RAGE blockade in rodent models of vascular injury.

References

Feb 1, 1997·Molecular Neurobiology·S Y Fu, T Gordon
Jul 10, 1999·Science·H WangK J Tracey
Jan 4, 2001·Journal of Neuropathology and Experimental Neurology·M TakeuchiZ Makita
Apr 5, 2001·American Journal of Physiology. Endocrinology and Metabolism·M P WautierJ L Wautier
Jun 19, 2002·Genes and Immunity·M A HofmannA M Schmidt
Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Nov 27, 2002·Circulation·Loredana G BucciarelliAnn Marie Schmidt
Mar 20, 2003·Microscopy Research and Technique·Rosario Donato
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Beatriz Rendon-MitchellHaichao Wang
Apr 3, 2003·The Journal of Clinical Investigation·Taichi SakaguchiYoshifumi Naka
Dec 9, 2003·The Journal of Biological Chemistry·Jong Sung ParkEdward Abraham
Jun 3, 2004·The Journal of Clinical Investigation·Birgit LiliensiekBernd Arnold
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yali ChenKevan C Herold
Oct 9, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Nicola TraversoM Adelaide Pronzato
Dec 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ling Ling RongAnn Marie Schmidt
Dec 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ling Ling RongAnn Marie Schmidt
Feb 9, 2005·The Journal of Experimental Medicine·Guellue CataldegirmenJean C Emond
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Colomba FalconeDiego Geroldi
Mar 8, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Colomba FalconeMariaclara Cuccia
Apr 23, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Giuseppina BastaRaffaele De Caterina
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ingrid E DumitriuPatrizia Rovere-Querini
Oct 15, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hidenori KoyamaYoshiki Nishizawa

❮ Previous
Next ❯

Citations

May 11, 2012·Future Medicinal Chemistry·Richard J Deane
Jun 26, 2013·Future Medicinal Chemistry·Aimalie L Hardaway, Izabela Podgorski
Dec 31, 2008·The Journal of Thoracic and Cardiovascular Surgery·David I SternbergJoshua R Sonett
Sep 9, 2006·Current Opinion in Lipidology·Geoffrey J Howlett, Kathryn J Moore
Feb 28, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eszter Herczenik, Martijn F B G Gebbink
Mar 12, 2009·Clinical Science·Anastasia Z KaleaBarry I Hudson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.